“…The first was the realization that Fus3, but not Kss1, is responsible for gradient tracking (Conlon, Gelin-Licht, Ganesan, Zhang, & Levchenko, 2016;Erdman & Snyder, 2001;Errede, Vered, Ford, Pena, & Elston, 2015;Hao et al, 2008;Hegemann et al, 2015; although another group reported a specific requirement for Kss1; Paliwal et al, 2007). This was surprising to us given that Fus3 and Kss1 are both activated by the same upstream protein kinases, and either MAPK can sustain mating transcription and elongated growth (Breitkreutz et al, 2001;Conlon et al, 2016;Erdman & Snyder, 2001;Errede et al, 2015;Hao et al, 2008;Hegemann et al, 2015;Paliwal et al, 2007;Roberts et al, 2000;Zeitlinger et al, 2003). In parallel experiments using phospho-p44/ p42 antibodies, we determined that gradient tracking is the result of the distinct temporal and dose-dependent activation properties of Fus3.…”